Close Menu

NEW YORK – Molecular diagnostic reagent developer BioGX and Bosch Healthcare Solutions, a subsidiary of the Bosch Group, announced Wednesday a partnership to develop point-of-care infectious disease tests for Bosch's Vivalytic platform.

Birmingham, Alabama-based BioGX will develop, manufacture, and supply reagents for the Vivalytic cartridges, along with providing custom reagent manufacturing services for Vivalytic open system users. The companies said they will work together to seek regulatory approvals in different countries for in vitro diagnostic use.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US has sent its formal notice of withdrawal from the World Health Organization, according to the Wall Street Journal.

Science reports that a draft spending bill would increase the US National Institutes of Health budget by 13 percent.

The Harvard Crimson reports that Harvard and MIT are suing the Department of Homeland Security and ICE over the new international student visa policy.

In Nucleic Acids Research this week: algorithm to determine molecular sequence types and other microbial features, computational method to uncover R-loop structures, and more.